相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Medullary Pain Facilitating Neurons Mediate Allodynia in Headache-Related Pain
Rebecca M. Edelmayer et al.
ANNALS OF NEUROLOGY (2009)
The blood-brain barrier in migraine treatment
L. Edvinsson et al.
CEPHALALGIA (2008)
Maximum effect of triptans in migraine? A comment
P. Tfelt-Hansen
CEPHALALGIA (2008)
Sumatriptan normalizes the migraine attack-related increase in brain serotonin synthesis
Y. Sakai et al.
NEUROLOGY (2008)
Use of plasma and brain unbound fractions to assess the extent of brain distribution of 34 drugs: Comparison of unbound concentration ratios to in vivo P-glycoprotein efflux ratios
J. Cory Kalvass et al.
DRUG METABOLISM AND DISPOSITION (2007)
Treatment-emergent CNS symptoms following triptan therapy are part of the attack
P. J. Goadsby et al.
CEPHALALGIA (2007)
A PET study exploring the laterality of brainstem activation in migraine using glyceryl trinitrate
SK Afridi et al.
BRAIN (2005)
Correlation between lipophilicity and triptan outcomes
J Pascual et al.
HEADACHE (2005)
Disruption of communication between peripheral and central trigeminovascular neurons mediates the antimigraine action of 5HT1B/1D receptor agonists
D Levy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
CNS effects of sumatriptan and rizatriptan
SD Silberstein et al.
CEPHALALGIA (2004)
Effects of acute or chronic administration of anti-migraine drugs sumatriptan and zolmitriptan on serotonin synthesis in the rat brain
CF Dobson et al.
CEPHALALGIA (2004)
Nitroglycerin-induced nNOS increase in rat trigeminal nucleus caudalis is inhibited by systemic administration of lysine acetylsalicylate but not of sumatriptan
A Pardutz et al.
CEPHALALGIA (2004)
Triptans and CNS side-effects: pharmacokinetic and metabolic mechanisms
DW Dodick et al.
CEPHALALGIA (2004)
Eletriptan metabolism by human hepatic CYP450 enzymes and transport by human P-glycoprotein
DC Evans et al.
DRUG METABOLISM AND DISPOSITION (2003)
Migraine medication attributes important for patient compliance: Concerns about side effects may delay treatment
RM Gallagher et al.
HEADACHE (2003)
The antimigraine 5-HT1B/1D receptor agonists, sumatriptan, zolmitriptan and dihydroergotamine, attenuate pain-related behaviour in a rat model of trigeminal neuropathic pain
V Kayser et al.
BRITISH JOURNAL OF PHARMACOLOGY (2002)
Triptans (serotonin, 5-HT1B/1D agonists) in migraine:: detailed results and methods of a meta-analysis of 53 trials
MD Ferrari et al.
CEPHALALGIA (2002)
CNS effects of sumatriptan and rizatriptan in healthy female volunteers
J van der Post et al.
CEPHALALGIA (2002)
Serotonergic effects and extracellular brain levels of eletriptan, zolmitriptan and sumatriptan in rat brain
DE Johnson et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2001)
Sumatriptan, 5-MT1D receptors and obsessive-compulsive disorder
LM Koran et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2001)
Cortical spreading depression produces increased cGMP levels in cortex and brain stem that is inhibited by tonabersat (SB-220453) but not sumatriptan
SJ Read et al.
BRAIN RESEARCH (2001)
Triptans in migraine - A comparative review of pharmacology, pharmacokinetics and efficacy
P Tfelt-Hansen et al.
DRUGS (2000)
Sumatriptan modifies cortical free radical release during cortical spreading depression - A novel antimigraine action for sumatriptan?
SJ Read et al.
BRAIN RESEARCH (2000)
Comparison of the efficacy of zolmitriptan and sumatriptan: issues in migraine trial design
G Geraud et al.
CEPHALALGIA (2000)
分享论文
